Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Twist Bioscience Corporation - Common Stock
(NQ:
TWST
)
32.78
+0.03 (+0.09%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 7, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Twist Bioscience Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Cathie Wood's Ark Invest Offloads $6.9M Worth of Coinbase, Robinhood Shares Each Amid Searing Bitcoin Rally — Nvidia Stock Also Shed
February 26, 2024
On Monday, Cathie Wood-led Ark Invest adjusted its portfolio, notably selling shares of cryptocurrency-related companies such as Robinhood Markets Inc (NASDAQ:HOOD) and Coinbase Global Inc (NASDAQ:
Via
Benzinga
Twist Bioscience to Present at Upcoming Investor Conferences
February 22, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Is The Stock Market Ready To Plunge? The Warning Signs Are Here...
February 21, 2024
Find out how to spot the exhaustion of demand and the bearish analogue you could refer to to anticipate the down move.
Via
Talk Markets
7 Stocks Cathie Wood Is Still Loading Up On in Q1
February 13, 2024
You won't find many timid bets among the Cathie Wood stocks she believes will dramatically alter our future.
Via
InvestorPlace
4 Analysts Have This To Say About Twist Bioscience
February 05, 2024
Via
Benzinga
Twist Bioscience Earnings Preview
February 01, 2024
Via
Benzinga
7 Sexy Stocks That Will Continue to Outperform in 2024
February 11, 2024
These outperforming stocks are prime candidates for increasing in value sharply this year and beyond. Discover the top picks.
Via
InvestorPlace
Cathie Wood Trims Nvidia, Shopify Stakes To Pump Whopping $40M Into Pinterest Despite Q4 Revenue Miss
February 08, 2024
Via
Benzinga
Cathie Wood's Ark Invest Sheds $2.8M Worth Of Nvidia Shares Amid AI Hype, Picks Up Robinhood Stock Worth $1.3M
February 07, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
February 07, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System
February 06, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications
February 06, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT
February 05, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Why Is DNA Synthesis Company Twist Bioscience Stock Trading Higher Today?
February 02, 2024
Twist Bioscience reported Q1 2024 earnings, beating revenue guidance and increasing FY24 guidance. Shares are up 7.16%.
Via
Benzinga
Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results
February 02, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Earnings Scheduled For February 2, 2024
February 02, 2024
Companies Reporting Before The Bell • W.W. Grainger (NYSE:GWW) is likely to report quarterly earnings at $8.05 per share on revenue of $4.04 billion.
Via
Benzinga
Twist Bioscience Corp Daily Investment Opportunity
January 25, 2024
Twist Bioscience is a public biotechnology company founded in 2013 and it’s based in South San Francisco. It manufactures synthetic DNA and DNA products for customers in a wide range of industries.
Via
Talk Markets
Twist Bioscience Expands Express Genes Rapid Synthesis Service
January 24, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin Expansion
January 17, 2024
Goldman Sachs upgrades Twist Bioscience as Express Genes launch addresses SynBio division's gross margin issues. With 5-7 days gene delivery, TWST taps into a previously inaccessible market, enhancing...
Via
Benzinga
Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday
January 17, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Twist Bioscience to Report Fiscal 2024 First Quarter Financial Results on Friday, February 2, 2024
January 16, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Biotech Playbook: Small Caps Show Momentum Peaking During
January 15, 2024
The momentum of selected stocks was strong up until early January was encouraging but we need less volatility in period ahead to conform a new bull market.
Via
Talk Markets
Twist Bioscience Corporation Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
January 08, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Appoints Adam Laponis as Chief Financial Officer
January 05, 2024
From
Twist Bioscience Corporation
Via
Business Wire
3 Genomics Stocks to Unlock the Future of Medicine
December 19, 2023
Genomics stocks stand to surge in 2024 after the FDA approved the nation's first gene-editing therapeutic for clinical use.
Via
InvestorPlace
Exposures
Product Safety
Twist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare Conference
December 18, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Tuesday Talk: CPI Data And FOMC Meeting Hold Back Market Breakout
December 12, 2023
While the market continues towards making new highs, it is falling short of making a breakout rally. Forthcoming CPI data and the upcoming FOMC meeting may be the catalyst for same.
Via
Talk Markets
Biotech Is Coming Back, Can The Run Last?
December 11, 2023
The rally can be attributed to lower interest rates and seasonal factors from the end of Q4 through January. But recently some major biopharmaceutical deals have supported the rally.
Via
Talk Markets
Five Best Performing Stocks Of The Top ETF Of November
December 01, 2023
Most stocks in ARKK’s portfolio delivered strong returns in November. These five led the way.
Via
Talk Markets
Topics
ETFs
Cramer Says No To This EV Maker, But Recommends This Major Automaker Stock: It 'Goes Up And Up'
November 21, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said no to Lucid Group, Inc.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.